Literature DB >> 10074875

Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients.

H G Nurnberg1, J Lauriello, P L Hensley, L M Parker, S J Keith.   

Abstract

OBJECTIVE: To evaluate the effect of sildenafil on iatrogenic serotonergic antidepressant-induced sexual dysfunction.
METHOD: Four outpatients (2 men, 2 women) who developed sexual dysfunction (erectile impotence, anorgasmia) during treatment with a serotonin reuptake inhibitor antidepressant for psychiatric disorder were selected. Each subject was initially prescribed sildenafil 50 mg to be taken approximately 1 hour before sexual activity. The dose was increased to 100 mg for a partial or failed response.
RESULTS: Four cases are detailed in case report fashion. All 4 had rapid reversal of their sexual dysfunction, usually with the first dose. Reversal equates to 1 successful use of sildenafil in each of 2 patients and 3 uses in 2 patients.
CONCLUSION: Sildenafil may be an effective treatment for serotonergic antidepressant-induced sexual dysfunction and deserves further evaluation in randomized placebo-controlled studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074875     DOI: 10.4088/jcp.v60n0107

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

Review 1.  Sexual side effects of antidepressant drugs.

Authors:  A J Gelenberg; P Delgado; H G Nurnberg
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 2.  Prevalence of and recent developments in female sexual dysfunction.

Authors:  R Shabsigh
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

Review 3.  The impact of the new sexual pharmaceuticals on sex therapy.

Authors:  M A Perelman
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

4.  Antidepressants causing sexual problems? Give her Viagra.

Authors:  Debra Stulberg; Bernard Ewigman
Journal:  J Fam Pract       Date:  2008-12       Impact factor: 0.493

Review 5.  Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.

Authors:  Alberto Briganti; Andrea Salonia; Federico Deho'; Giuseppe Zanni; Luigi Barbieri; Patrizio Rigatti; Francesco Montorsi
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

Review 6.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 7.  Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls.

Authors:  P L Hensley; H G Nurnberg
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 8.  Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment.

Authors:  Julia Jill K Warnock
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

9.  Oral pharmacotherapy and the contemporary evaluation and management of erectile dysfunction.

Authors:  Gregory A Broderick
Journal:  Rev Urol       Date:  2003

10.  Sildenafil in the Treatment of SSRI-Induced Sexual Dysfunction: A Pilot Study.

Authors:  Marina Damis; Yatin Patel; George M. Simpson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.